CMG Pharmaceutical Co., Ltd. (KOSDAQ:058820)
South Korea · Delayed Price · Currency is KRW 1,876.00
-33.00 (-1.73%)
Oct 10, 2025, 3:30 PM KST
CMG Pharmaceutical Market Cap
CMG Pharmaceutical has a market cap or net worth of 277.04 billion as of October 10, 2025. Its market cap has decreased by -5.91% in one year.
Market Cap
277.04B
Enterprise Value
285.13B
Revenue
94.73B
Ranking
n/a
PE Ratio
n/a
Stock Price
1,876.00
Market Cap Chart
Since March 1, 2002, CMG Pharmaceutical's market cap has increased from 11.27B to 277.04B, an increase of 2,358.25%. That is a compound annual growth rate of 14.51%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 10, 2025 | 277.04B | 12.82% |
| Dec 30, 2024 | 245.56B | -26.64% |
| Dec 28, 2023 | 334.73B | 12.09% |
| Dec 29, 2022 | 298.62B | -43.94% |
| Dec 30, 2021 | 532.65B | -33.65% |
| Dec 30, 2020 | 802.80B | 36.00% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 71.81T |
| Celltrion | 38.64T |
| ALTEOGEN | 25.22T |
| Yuhan | 8,969.60B |
| SK Biopharmaceuticals | 8,144.58B |
| Peptron | 7,006.86B |
| PharmaResearch | 5,714.31B |
| LigaChem Biosciences | 5,545.53B |